511 related articles for article (PubMed ID: 18284654)
1. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity.
Miljkovic MM; Dobric S; Dragojevic-Simic V
J Clin Pharm Ther; 2012 Apr; 37(2):196-203. PubMed ID: 21718339
[TBL] [Abstract][Full Text] [Related]
3. Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity.
Miljkovic MM; Dobric S; Dragojevic-Simic V
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):272-85. PubMed ID: 21351309
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two clinical scales for causality assessment in hepatotoxicity.
Lucena MI; Camargo R; Andrade RJ; Perez-Sanchez CJ; Sanchez De La Cuesta F
Hepatology; 2001 Jan; 33(1):123-30. PubMed ID: 11124828
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous reports of assumed herbal hepatotoxicity by black cohosh: is the liver-unspecific Naranjo scale precise enough to ascertain causality?
Teschke R; Schmidt-Taenzer W; Wolff A
Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):567-82. PubMed ID: 21702069
[TBL] [Abstract][Full Text] [Related]
6. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
[TBL] [Abstract][Full Text] [Related]
7. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
[TBL] [Abstract][Full Text] [Related]
8. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
Teschke R; Wolff A
Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865
[TBL] [Abstract][Full Text] [Related]
9. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
10. Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia.
Teschke R; Schulze J
Drug Saf; 2012 Dec; 35(12):1091-7. PubMed ID: 22897137
[TBL] [Abstract][Full Text] [Related]
11. Is the Naranjo probability scale accurate enough to ascertain causality in drug-induced hepatotoxicity?
García-Cortés M; Lucena MI; Andrade RJ; Camargo R; Alcántara R
Ann Pharmacother; 2004 Sep; 38(9):1540-1. PubMed ID: 15266043
[No Abstract] [Full Text] [Related]
12. Comparison of WHO-UMC and Naranjo Scales for Causality Assessment of Reported Adverse Drug Reactions.
Pandit S; Soni D; Krishnamurthy B; Belhekar MN
J Patient Saf; 2024 Jun; 20(4):236-239. PubMed ID: 38345209
[TBL] [Abstract][Full Text] [Related]
13. Causality assessment methods in drug induced liver injury: strengths and weaknesses.
García-Cortés M; Stephens C; Lucena MI; Fernández-Castañer A; Andrade RJ
J Hepatol; 2011 Sep; 55(3):683-691. PubMed ID: 21349301
[TBL] [Abstract][Full Text] [Related]
14. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the reproducibility of the Naranjo Adverse Drug Reaction Probability Scale score in published case reports.
Liang R; Borgundvaag B; McIntyre M; Thwaites C; Ragan K; Wyllie A
Pharmacotherapy; 2014 Nov; 34(11):1159-66. PubMed ID: 25266970
[TBL] [Abstract][Full Text] [Related]
16. Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?
Kane-Gill SL; Kirisci L; Pathak DS
Ann Pharmacother; 2005 Nov; 39(11):1823-7. PubMed ID: 16204392
[TBL] [Abstract][Full Text] [Related]
17. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
Carrascosa MF; Lucena MI; Andrade RJ; Caviedes JR; Lavín AC; Mones JC; Rivero AP; Serrano VB
Clin Ther; 2009 May; 31(5):1014-9. PubMed ID: 19539102
[TBL] [Abstract][Full Text] [Related]
18. A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions.
Belhekar MN; Taur SR; Munshi RP
Indian J Pharmacol; 2014; 46(1):117-20. PubMed ID: 24550597
[TBL] [Abstract][Full Text] [Related]
19. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods.
Teschke R; Frenzel C; Schulze J; Eickhoff A
World J Gastroenterol; 2013 May; 19(19):2864-82. PubMed ID: 23704820
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different methods for causality assessment of adverse drug reactions.
Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
